Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Healthcare (NHC) EBITDA Margin: 2009-2024

Historic EBITDA Margin for National Healthcare (NHC) over the last 16 years, with FY2024 value amounting to 6.56%.

  • National Healthcare's EBITDA Margin rose 12400.0% to 7.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.0%, marking a year-over-year increase of 14500.0%. This contributed to the annual value of 6.56% for FY2024, which is 15500.0% up from last year.
  • According to the latest figures from FY2024, National Healthcare's EBITDA Margin is 6.56%, which was up 15500.0% from 5.0% recorded in FY2023.
  • In the past 5 years, National Healthcare's EBITDA Margin ranged from a high of 6.56% in FY2024 and a low of 2.94% during FY2022
  • Moreover, its 5-year median value for EBITDA Margin was 4.74% (2021), whereas its average is 4.79%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first tumbled by -18000bps in 2022, then surged by 20700bps in 2023.
  • Annual analysis of 5 years shows National Healthcare's EBITDA Margin stood at 4.68% in 2020, then rose by 1bps to 4.74% in 2021, then tumbled by -38bps to 2.94% in 2022, then soared by 70bps to 5.0% in 2023, then surged by 31bps to 6.56% in 2024.
  • Its last three reported values are 6.56% in FY2024, 5.0% for FY2023, and 2.94% during FY2022.